Health
What's Going On With SciSparc Shares On Friday? - SciSparc (NASDAQ:SPRC)
xCruzo Brief
SciSparc (NASDAQ:SPRC) shares fell sharply in Friday premarket trading, dropping 20.31% to $6.93, as investors weigh recent company updates against broader market gains. S&P 500 futures were up about 0.4% at the time. The news being highlighted includes SciSparc subsidiary NeuroThera Labs completing internal validation of a proprietary quantum sampling workflow intended to improve clinical trial data analysis. Separately, NeuroThera initiated a Phase IIb clinical trial site at Hannover Medical School (MHH) in Hanover, Germany, for SCI-110, a cannabinoid-based treatment candidate for adult Tourette syndrome.
xCruzo quick-read summary • Source: Benzinga • Read the full article for complete information.
xCruzo
Bitter pill: are you wasting your money on supplements?
Driver charged with DUI after crashing head-on into tree along Hwy. 115 - Now Georgia
Best of Arkansas 2026: Winners, finalists and faves - Arkansas Times
Millions of prescription eye drops recalled by FDA
Escojo el racismo argentino": la tremenda explicación de una tiktoker boliviana que se hizo viral en medio de la campaña anti Argentina
Combatir el ébola en el Congo empieza por frenar el hambre: "La alimentación es la primera línea de contención"
Qué significa el gesto que Montero hizo otra vez a la cámara
Comparativa de las mejores creatinas 2026